United Therapeutics (UTHR) Misses Q1 EPS by 117c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $545.96 +0.10%
EPS Growth %: +12.6%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +12.6%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.82, $1.17 worse than the analyst estimate of $6.99. Revenue for the quarter came in at $781.5 million versus the consensus estimate of $798.85 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026
- Circle board member resigns after nearly 13 years of service
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
